These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28675044)

  • 1. Featured Article: Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles.
    Kernan DL; Wen AM; Pitek AS; Steinmetz NF
    Exp Biol Med (Maywood); 2017 Aug; 242(14):1405-1411. PubMed ID: 28675044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer.
    Bruckman MA; Czapar AE; VanMeter A; Randolph LN; Steinmetz NF
    J Control Release; 2016 Jun; 231():103-13. PubMed ID: 26941034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Loaded Plant-Virus Based Nanoparticles for Cancer Drug Delivery.
    Bruckman MA; Czapar AE; Steinmetz NF
    Methods Mol Biol; 2018; 1776():425-436. PubMed ID: 29869258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion and Uptake of Tobacco Mosaic Virus as Therapeutic Carrier in Tumor Tissue: Effect of Nanoparticle Aspect Ratio.
    Chariou PL; Lee KL; Pokorski JK; Saidel GM; Steinmetz NF
    J Phys Chem B; 2016 Jul; 120(26):6120-9. PubMed ID: 27045770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates.
    Law CL; Cerveny CG; Gordon KA; Klussman K; Mixan BJ; Chace DF; Meyer DL; Doronina SO; Siegall CB; Francisco JA; Senter PD; Wahl AF
    Clin Cancer Res; 2004 Dec; 10(23):7842-51. PubMed ID: 15585616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elongated Plant Virus-Based Nanoparticles for Enhanced Delivery of Thrombolytic Therapies.
    Pitek AS; Wang Y; Gulati S; Gao H; Stewart PL; Simon DI; Steinmetz NF
    Mol Pharm; 2017 Nov; 14(11):3815-3823. PubMed ID: 28881141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.
    Murray AA; Wang C; Fiering S; Steinmetz NF
    Mol Pharm; 2018 Sep; 15(9):3700-3716. PubMed ID: 29798673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco mosaic virus delivery of mitoxantrone for cancer therapy.
    Lin RD; Steinmetz NF
    Nanoscale; 2018 Aug; 10(34):16307-16313. PubMed ID: 30129956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas.
    Gerber HP; Kung-Sutherland M; Stone I; Morris-Tilden C; Miyamoto J; McCormick R; Alley SC; Okeley N; Hayes B; Hernandez-Ilizaliturri FJ; McDonagh CF; Carter PJ; Benjamin D; Grewal IS
    Blood; 2009 Apr; 113(18):4352-61. PubMed ID: 19147785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco Mosaic Virus-Delivered Cisplatin Restores Efficacy in Platinum-Resistant Ovarian Cancer Cells.
    Franke CE; Czapar AE; Patel RB; Steinmetz NF
    Mol Pharm; 2018 Aug; 15(8):2922-2931. PubMed ID: 28926265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity.
    Francisco JA; Cerveny CG; Meyer DL; Mixan BJ; Klussman K; Chace DF; Rejniak SX; Gordon KA; DeBlanc R; Toki BE; Law CL; Doronina SO; Siegall CB; Senter PD; Wahl AF
    Blood; 2003 Aug; 102(4):1458-65. PubMed ID: 12714494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft-Matter Nanorods.
    Shukla S; Eber FJ; Nagarajan AS; DiFranco NA; Schmidt N; Wen AM; Eiben S; Twyman RM; Wege C; Steinmetz NF
    Adv Healthc Mater; 2015 Apr; 4(6):874-82. PubMed ID: 25641794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-Loaded Tobacco Mosaic Virus for Ovarian Cancer Treatment.
    Zhao Z; Simms A; Steinmetz NF
    Biomacromolecules; 2022 Oct; 23(10):4379-4387. PubMed ID: 36053908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco Mosaic Virus-Based 1D Nanorod-Drug Carrier via the Integrin-Mediated Endocytosis Pathway.
    Tian Y; Gao S; Wu M; Liu X; Qiao J; Zhou Q; Jiang S; Niu Z
    ACS Appl Mater Interfaces; 2016 May; 8(17):10800-7. PubMed ID: 27062971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The
    Nkanga CI; Chung YH; Shukla S; Zhou J; Jokerst JV; Steinmetz NF
    Biomater Sci; 2021 Oct; 9(21):7134-7150. PubMed ID: 34591046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A developed antibody-drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line.
    Abdollahpour-Alitappeh M; Hashemi Karouei SM; Lotfinia M; Amanzadeh A; Habibi-Anbouhi M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1-8. PubMed ID: 29523024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles.
    Pitek AS; Hu H; Shukla S; Steinmetz NF
    ACS Appl Mater Interfaces; 2018 Nov; 10(46):39468-39477. PubMed ID: 30403330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of Tobacco Mosaic Virus-Binding Peptides for Biotechnology Applications.
    Chan SK; Steinmetz NF
    Chembiochem; 2022 Jun; 23(11):e202200040. PubMed ID: 35320626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HB22.7-vcMMAE antibody-drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicity.
    Abuhay M; Kato J; Tuscano E; Barisone GA; Sidhu RS; O'Donnell RT; Tuscano JM
    Cancer Immunol Immunother; 2016 Oct; 65(10):1169-75. PubMed ID: 27506529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Aspect Ratio Nanotubes Formed by Tobacco Mosaic Virus for Delivery of Photodynamic Agents Targeting Melanoma.
    Lee KL; Carpenter BL; Wen AM; Ghiladi RA; Steinmetz NF
    ACS Biomater Sci Eng; 2016 May; 2(5):838-844. PubMed ID: 28713855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.